Cheaper Hydrolyzed Collagen Powder, Bulk Protein Powder

Name: Cheaper Hydrolyzed Collagen Powder, Bulk Protein Powder
Brand: Xiamen Gelken Gelatin Co., Ltd.
SKU: 898570215

Fujian, ChinaXiamen Gelken Gelatin Co., Ltd.

US$6.00-8.00

1,000 kg

Sample price:US$6.00/kg.Request sample

Product profile

Customization

Available

CAS No.

9000-70-8

Formula

C102h151o39n31

EINECS

232-554-6

Nutritional Value

Nutritional

Certification

ISO, Halal, SGS

Packaging Material

Woven Bag Outside and PE Bag Inside.

Storage Method

Keep in a Cool and Dry Place, at Temperature From

Shelf Life

5 Years

Type

Emulsifiers, Nutrition Enhancers, Stabilizers, Thi

Product Name

Hydrolyzed Collagen

Function

Function Food

Protein Content

Greater Than 90%

Dosage Form

Powder

Color

White or Yellowish

Smell

Odorless

Impurity

No Visible Impurity

Solubility

100% Water Soluble

Main Ingredient

Animal Skin/ Bone

Application

Powdered Drinks, Nutrition Bars, Confectionery, Da

Delivery Time

14 Days

Total Bacteria Count

<100

Salmonella

Negative

Staphylococcus Aureus

Negative

Transport Package

25kg/Bag, Woven Bag Outside and PE Bag Inside.

Specification

25kg/bag

Trademark

Gelken

Origin

China

HS Code

35040090

Production Capacity

5000 Tons Per Year

Company profile

Exhibition ExperienceYears of Export ExperienceManagement CertificationHigh Repeat Buyers Choice

Xiamen Gelken Gelatin Co., Ltd.

Fujian, China

Business Type: Manufacturer/FactoryExport Year: 2011-05-18Nearest Port: XIAMEN PORT, CHINA, SHANGHAI PORT, SHENZHEN PORTAverage Response Time: ≤3.60hTerms of Payment: LC, T/T, PayPal, etc.International Commercial Terms(Incoterms): FOB, CFR, CIF, EXW

AI-Powered supplier vetting

SummaryXiamen Gelken Gelatin Co., Ltd. is identified as a China-based manufacturer/factory engaged in health, medicine, chemicals, and food-related products. The supplier offers gelatin, collagen, and related materials, with stated production facilities, five production lines, 50 quality-control staff, and certifications including ISO 9001, ISO 22000, GMP, and HACCP; HALAL is also stated in the company description. It holds stated drug and edible production licenses and has exported since 2011, with exports representing 90% of total sales and self-operated import/export rights. An SGS audit record is available for March 3, 2025 to March 2, 2026, but the recorded evaluation result is not explained. Evidence is insufficient for after-sales service, financial credibility, innovation, customization, and customer cases. Production information is positive but includes differing stated gelatin and total output figures across records, which should be reconciled.

Supplier typeThe supplier is identified as both a Manufacturer/Factory and a limited company, with its business associated with health and medicine, chemicals, and agriculture and food. A separate record labels the associated-company industry as wholesale and retail, but the direct supplier classification is manufacturer/factory.

CertificationsThe supplier states ISO 22000, ISO 9001, GMP, HALAL, and HACCP compliance, while another record confirms ISO 9001, ISO 22000, GMP, and HACCP. It also states possession of drug and edible production licenses, and an SGS audit record covers March 3, 2025 through March 2, 2026; however, the audit result code is not explained.

Production capacityThe supplier states production of gelatin, collagen, and related products, with five production lines, 50 quality-control staff, and reported outputs of 30,000 tons of jelly glue, 15,000 tons of gelatin, and 5,000 tons of collagen. The company description separately states annual production of 12,000 metric tons, and inventory, outsourcing procedures, capacity reconciliation, and valid manufacturing contracts are marked unknown, so capacity evidence is positive but internally inconsistent.

Customization capabilityThe company states it can provide gelatin with different applications according to customer requirements. Nevertheless, ODM, OEM, 3D design, and new-product development capabilities are marked unknown, so the evidence supports application-related flexibility but not a broader customization capability assessment.